Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia

Juha Rasanen, Anna Girsen, Xinfang Lu, Jodi Lapidus, Melissa Standley, Ashok Reddy, Surendra Dasari, Archana Thomas, Thomas Jacob, Anneli Pouta, Helja Marja Surcel, Jorge Tolosa, Michael G. Gravett, Srinivasa R. Nagalla

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We systematically characterized maternal serum proteome in women with clinical preeclampsia (PE) and asymptomatic women in early pregnancy that subsequently developed PE. Clinical PE cohort comprised 30 patients with mild PE, 30 with severe PE, and 58 normotensive women. Preclinical PE cohort included 149 women whose serum samples were collected at 8-14 gestational weeks and in whom 30 women later developed mild and 40 severe PE. Serum proteome was analyzed and enzyme-linked immunosorbent assays were used for protein quantification. In Clinical PE, fibronectin, pappalysin-2, choriogonadotropin-β, apolipoprotein C-III, cystatin-C, vascular endothelial growth factor receptor-1, and endoglin were more abundant compared to normotensive women. In preclinical PE, differently expressed proteins included placental, vascular, transport, matrix, and acute phase proteins. Angiogenic and antiangiogenic proteins were not significant. We conclude that placental and antiangiogenic proteins are abundant in clinical PE. In preclinical PE, proteomic profile is distinct and different from that in clinical PE.

Original languageEnglish (US)
Pages (from-to)4274-4281
Number of pages8
JournalJournal of Proteome Research
Volume9
Issue number8
DOIs
StatePublished - Aug 6 2010

Fingerprint

Pre-Eclampsia
Proteomics
Mothers
Proteome
Serum
Proteins
Apolipoprotein C-III
Vascular Endothelial Growth Factor Receptor-1
Cystatin C
Immunosorbents
Acute-Phase Proteins
Chorionic Gonadotropin
Fibronectins
Pregnancy Proteins
Assays
Enzymes
Angiogenic Proteins
Blood Vessels
Enzyme-Linked Immunosorbent Assay
Pregnancy

Keywords

  • Fetus
  • Hypertensive Disorders
  • Pregnancy
  • Proteome

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. / Rasanen, Juha; Girsen, Anna; Lu, Xinfang; Lapidus, Jodi; Standley, Melissa; Reddy, Ashok; Dasari, Surendra; Thomas, Archana; Jacob, Thomas; Pouta, Anneli; Surcel, Helja Marja; Tolosa, Jorge; Gravett, Michael G.; Nagalla, Srinivasa R.

In: Journal of Proteome Research, Vol. 9, No. 8, 06.08.2010, p. 4274-4281.

Research output: Contribution to journalArticle

Rasanen, J, Girsen, A, Lu, X, Lapidus, J, Standley, M, Reddy, A, Dasari, S, Thomas, A, Jacob, T, Pouta, A, Surcel, HM, Tolosa, J, Gravett, MG & Nagalla, SR 2010, 'Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia', Journal of Proteome Research, vol. 9, no. 8, pp. 4274-4281. https://doi.org/10.1021/pr100198m
Rasanen, Juha ; Girsen, Anna ; Lu, Xinfang ; Lapidus, Jodi ; Standley, Melissa ; Reddy, Ashok ; Dasari, Surendra ; Thomas, Archana ; Jacob, Thomas ; Pouta, Anneli ; Surcel, Helja Marja ; Tolosa, Jorge ; Gravett, Michael G. ; Nagalla, Srinivasa R. / Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. In: Journal of Proteome Research. 2010 ; Vol. 9, No. 8. pp. 4274-4281.
@article{8a8252f2e8c443069c6bfd0fa3daa599,
title = "Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia",
abstract = "We systematically characterized maternal serum proteome in women with clinical preeclampsia (PE) and asymptomatic women in early pregnancy that subsequently developed PE. Clinical PE cohort comprised 30 patients with mild PE, 30 with severe PE, and 58 normotensive women. Preclinical PE cohort included 149 women whose serum samples were collected at 8-14 gestational weeks and in whom 30 women later developed mild and 40 severe PE. Serum proteome was analyzed and enzyme-linked immunosorbent assays were used for protein quantification. In Clinical PE, fibronectin, pappalysin-2, choriogonadotropin-β, apolipoprotein C-III, cystatin-C, vascular endothelial growth factor receptor-1, and endoglin were more abundant compared to normotensive women. In preclinical PE, differently expressed proteins included placental, vascular, transport, matrix, and acute phase proteins. Angiogenic and antiangiogenic proteins were not significant. We conclude that placental and antiangiogenic proteins are abundant in clinical PE. In preclinical PE, proteomic profile is distinct and different from that in clinical PE.",
keywords = "Fetus, Hypertensive Disorders, Pregnancy, Proteome",
author = "Juha Rasanen and Anna Girsen and Xinfang Lu and Jodi Lapidus and Melissa Standley and Ashok Reddy and Surendra Dasari and Archana Thomas and Thomas Jacob and Anneli Pouta and Surcel, {Helja Marja} and Jorge Tolosa and Gravett, {Michael G.} and Nagalla, {Srinivasa R.}",
year = "2010",
month = "8",
day = "6",
doi = "10.1021/pr100198m",
language = "English (US)",
volume = "9",
pages = "4274--4281",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia

AU - Rasanen, Juha

AU - Girsen, Anna

AU - Lu, Xinfang

AU - Lapidus, Jodi

AU - Standley, Melissa

AU - Reddy, Ashok

AU - Dasari, Surendra

AU - Thomas, Archana

AU - Jacob, Thomas

AU - Pouta, Anneli

AU - Surcel, Helja Marja

AU - Tolosa, Jorge

AU - Gravett, Michael G.

AU - Nagalla, Srinivasa R.

PY - 2010/8/6

Y1 - 2010/8/6

N2 - We systematically characterized maternal serum proteome in women with clinical preeclampsia (PE) and asymptomatic women in early pregnancy that subsequently developed PE. Clinical PE cohort comprised 30 patients with mild PE, 30 with severe PE, and 58 normotensive women. Preclinical PE cohort included 149 women whose serum samples were collected at 8-14 gestational weeks and in whom 30 women later developed mild and 40 severe PE. Serum proteome was analyzed and enzyme-linked immunosorbent assays were used for protein quantification. In Clinical PE, fibronectin, pappalysin-2, choriogonadotropin-β, apolipoprotein C-III, cystatin-C, vascular endothelial growth factor receptor-1, and endoglin were more abundant compared to normotensive women. In preclinical PE, differently expressed proteins included placental, vascular, transport, matrix, and acute phase proteins. Angiogenic and antiangiogenic proteins were not significant. We conclude that placental and antiangiogenic proteins are abundant in clinical PE. In preclinical PE, proteomic profile is distinct and different from that in clinical PE.

AB - We systematically characterized maternal serum proteome in women with clinical preeclampsia (PE) and asymptomatic women in early pregnancy that subsequently developed PE. Clinical PE cohort comprised 30 patients with mild PE, 30 with severe PE, and 58 normotensive women. Preclinical PE cohort included 149 women whose serum samples were collected at 8-14 gestational weeks and in whom 30 women later developed mild and 40 severe PE. Serum proteome was analyzed and enzyme-linked immunosorbent assays were used for protein quantification. In Clinical PE, fibronectin, pappalysin-2, choriogonadotropin-β, apolipoprotein C-III, cystatin-C, vascular endothelial growth factor receptor-1, and endoglin were more abundant compared to normotensive women. In preclinical PE, differently expressed proteins included placental, vascular, transport, matrix, and acute phase proteins. Angiogenic and antiangiogenic proteins were not significant. We conclude that placental and antiangiogenic proteins are abundant in clinical PE. In preclinical PE, proteomic profile is distinct and different from that in clinical PE.

KW - Fetus

KW - Hypertensive Disorders

KW - Pregnancy

KW - Proteome

UR - http://www.scopus.com/inward/record.url?scp=77955454030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955454030&partnerID=8YFLogxK

U2 - 10.1021/pr100198m

DO - 10.1021/pr100198m

M3 - Article

C2 - 20568817

AN - SCOPUS:77955454030

VL - 9

SP - 4274

EP - 4281

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 8

ER -